ロード中...

Efficacy and tolerability of once-daily 160 mg valsartan in Chinese patients with mild to moderate hypertension

The present multicentre, prospective, open-label, single treatment arm study (Val-Perfect) examined the efficacy and tolerability of once-daily valsartan monotherapy (80 mg for two weeks, followed by 160 mg for eight weeks) in 195 Chinese patients with mild to moderate hypertension, using office, ho...

詳細記述

保存先:
書誌詳細
出版年:Exp Ther Med
主要な著者: Sun, Ningling, Feng, Yingqing, Gao, Pingjin, Chen, Xiaoping, Qi, Litong, Zhang, Shuyang, Dong, Yugang, Yang, Xinchun, Li, Xinli, Chen, Yundai, Liu, Lingli
フォーマット: Artigo
言語:Inglês
出版事項: D.A. Spandidos 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5403463/
https://ncbi.nlm.nih.gov/pubmed/28450950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2017.4051
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!